Meeder Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Meeder Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,045	Closed	-$919K	–	1850
2017 Q4	$919K	Buy	17,045 +1,653	+11%	+$90.4K	0.08%	248
2017 Q3	$877K	Buy	15,392 +5,414	+54%	+$317K	0.1%	247
2017 Q2	$600K	Buy	9,978 +2,625	+36%	+$149K	0.06%	333
2017 Q1	$401K	Buy	+7,353	New	+$362K	0.04%	413

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Meeder Asset Management's BIVV Position: Q1 2018 in Review

Meeder Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 17,045 shares — an estimated $919K sold.

Meeder Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $919K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Meeder Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Meeder Asset Management sold 17,045 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $919K.
Meeder Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Meeder Asset Management's Bioverativ Inc. Common Stock position peaked at $919K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.